Comerica Bank’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.54K Sell
19
-25
-57% -$2.11K ﹤0.01% 3546
2025
Q3
$2.87K Buy
44
+19
+76% +$1.13K ﹤0.01% 3481
2025
Q2
$1.33K Buy
25
+8
+47% +$376 ﹤0.01% 3555
2025
Q1
$839 Buy
17
+2
+13% +$111 ﹤0.01% 3578
2024
Q4
$968 Sell
15
-6
-29% -$347 ﹤0.01% 3571
2024
Q3
$1.03K Buy
21
+18
+600% +$845 ﹤0.01% 3571
2024
Q2
$120 Sell
3
-16
-84% -$544 ﹤0.01% 3673
2024
Q1
$1.21K Buy
+19
New +$1.23K ﹤0.01% 3602

Other funds holding IRON

Comerica Bank's IRON Position: Q4 2025 in Review

Comerica Bank reduced its Disc Medicine (IRON) stake by 57% in Q4 2025, selling an estimated $2.11K and leaving 19 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #3546.

Comerica Bank first reported a position in IRON in Q1 2024 and has held it in 8 quarters since. The position peaked at $2.87K in Q3 2025. 196 funds tracked by Wall St. Rank hold IRON as of Q4 2025.

  • Comerica Bank held 19 shares of Disc Medicine worth $1.54K as of Q4 2025.
  • Comerica Bank sold 25 Disc Medicine shares in Q4 2025, an estimated $2.11K.
  • Disc Medicine made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3546 holding.
  • Comerica Bank first reported a position in Disc Medicine in Q1 2024 and has held it in 8 quarters since.
  • Comerica Bank's Disc Medicine position peaked at $2.87K in Q3 2025.
  • 196 funds tracked by Wall St. Rank held Disc Medicine as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.